key: cord-0790635-5s25jv8x
authors: Ordonez-Jimenez, F.; Blanco-Rodriguez, R.; Almocera, A. E. S.; Chinney-Herrera, G.; Hernandez Vargas, E. A.
title: Quantifying antibody dynamics of severe and non-severe patients with COVID-19
date: 2022-02-24
journal: nan
DOI: 10.1101/2022.02.23.22271403
sha: 288ac60a446573a541e4c81c5e4d4d0b5dcc172a
doc_id: 790635
cord_uid: 5s25jv8x

COVID-19 pandemic is a major public health threat with unanswered questions regarding the role of the immune system in the severity level of the disease. In this paper, based on antibody kinetic data of patients with different disease severity, topological data analysis highlights clear differences in the shape of antibody dynamics between three groups of patients, which were non-severe, severe, and one intermediate case of severity. Subsequently, different mathematical models were developed to quantify the dynamics between the different severity groups. The best model was the one with the lowest media value of Akaike Information Criterion for all groups of patients. Although it has been reported high IgG level in severe patients, our findings suggest that IgG antibodies in severe patients may be less effective than non-severe patients due to early B cell production and early activation of the seroconversion process from IgM to IgG antibody.

diagrams are inconclusive. From the above we can conclude that high IgG antibody levels in the first weeks may be 87 an indicator of a tendency towards a more severe disease state. 88 Of the 262 patients considered in the previous analysis, longitudinal samples were obtained from 41 of them. For 89 the most part, samples were taken at three-day intervals. In this dataset the ID of each patient was also considered so 90 that the mapper algorithm recognizes the samples coming from the same person, so the points are in ℝ 5 . In Figure 4 91 shows the resulting graph colored according to the severity of the patients, the tail (group F) containing nodes with a 92 large number of samples followed by a circular shape (group G) that ends with two distinct protrusions (group D and : Graph generated with the Mapper algorithm using 41 longitudinal samples with the nodes colored by severity percentage. We can observe four main groups, in group D all nodes contain samples of severe patients, while in group E the percentage of severity varies between 0% and 90%. in groups F and G there are no samples of severe patients, however they differ with respect to the number of elements.

contain samples of severe patients, while in group E the percentage of severity varies between 0% and 90%. On the 96 other hand, in groups F and G there are no samples of severe patients, however they differ with respect to the number 97 of elements and the form in which they are presented. In group F all nodes have at least 12 elements (except for a 98 single node) and those in group G have at most 11. The complexity and, at times, redundancy of immune responses to infections often result in arduous and expensive 101 experimental settings when attempting to identify the key components and their temporal contributions. To dissect 102 the dynamics observed in patients with COVID-19, mathematical modelling was employed not only as a quantitative 103 recapitulation of experimental data but as a tool to support or reject less favourable hypotheses on the basis of various 104 mathematical models as "thought experiments" using the Akaike Information Criterion (AIC) for the model selection 105 process. We considered six different models. We will now describe three models that seem relevant to us; models 2, 

Page 5 of 19

. CC-BY-NC-ND 4.0 International license It is made available under a to display the preprint in perpetuity.

is the author/funder, who has granted medRxiv a license (which was not certified by peer review) holder for this preprint 

where is the rate of viral replication, the terms , and are the clearance rate of the virus by the 110 immune response T cells, IgM and IgG respectively. Clearance rate of the virus is . Previous modelling work has 111 suggested using half of the detection levels (less than 50 copies/ml) as initial viral concentration (0); however, for 112 patients with COVID-19, (0) has been estimated approximately in 0.31 copies/ml using a regression model [16] . The Equation (9) refers to the IgM dynamic. The model infers that the production of antibodies is not simultaneous but 128 independent, because IgM is considered a temporary antibody, in contrast to IgG, which shows prolonged immunity, 129 and that the seroconversion process suggests the early production of IgM for its later conversion to IgG. This serocon-

Page 6 of 19

. CC-BY-NC-ND 4.0 International license It is made available under a to display the preprint in perpetuity.

is the author/funder, who has granted medRxiv a license (which was not certified by peer review) holder for this preprint The copyright this version posted February 24, 2022. ; https://doi.org/10.1101/2022.02.23.22271403 doi: medRxiv preprint seroconversion and is the maximum capacity of this process. Figure 5 shows the complexity of the process described 135 by the following model:

Page 7 of 19

. CC-BY-NC-ND 4.0 International license It is made available under a to display the preprint in perpetuity.

is the author/funder, who has granted medRxiv a license (which was not certified by peer review) holder for this preprint In this section we perform a sensitivity analysis of Model 6, since it was the one with the best AIC score. To begin 138 with, Eqs. (11)-(15) can be transformed into the following dimensionless form:

where the function  is defined by ( , ) = ∕( + ) with ≥ 2, and the derivatives are with respect to dimensionless time = . And the overline symbols are the dimensionless parameter that can be obtained by substituting in Eqs. (11)-(15) the variables defined by:

For convenience, we call an equilibrium point with viral load virus-free when = 0 and virus-positive when 140 > 0. We will only consider equilibrium points with non-negative coordinates. Basic computation yields exactly one 141 virus-free equilibrium which is 0 ∶= (0, 1, 0, 0, 0).

Let ( ) denote the following Jacobian matrix:

where  = ∕ and

Page 8 of 19

. CC-BY-NC-ND 4.0 International license It is made available under a to display the preprint in perpetuity.

is the author/funder, who has granted medRxiv a license (which was not certified by peer review) holder for this preprint The copyright this version posted February 24, 2022. ;

Then 0 is asymptotically stable for < 0 and non-hyperbolic for = 0. If > 0, then 0 is an unstable saddle with 143 a four-dimensional stable manifold and a one-dimensional unstable manifold. 144 Proof. Evaluating the Jacobian matrix at 0 yields

which implies that 0 is asymptotically stable for < 0 and is non-hyperbolic for = 0. If > 0, then ( 0 ) has 145 exactly one positive eigenvalue and four negative eigenvalues. Hence by the Stable Manifold Theorem, 0 is an 146 unstable saddle with a four-dimensional stable manifold and a one-dimensional unstable manifold.

Remark. In the case where 0 becomes a saddle for > 0, the solutions 1 ( ) such that 1 ( ) → 0 at → ∞ form presented a significant temporal change of IgG antibody data and fit our models to that data; of these 39 patients, 3 that Model 6 had a better score for non-severe patients, but was not the best for severe patients. However, the difference 163 between the score of Model 6 in non-severe with the rest of the models is greater than comparing Model 4 to 6 in the 164 severe patient group, therefore we chose Model 6 as the one that best explains the viral dynamic and immune response.

The AIC scores can be consulted in the Supplementary Material. The parameters , and presented little variation between patients, even between severe and non-severe patients; is the author/funder, who has granted medRxiv a license (which was not certified by peer review) holder for this preprint severe patients is not large enough to give conclusive results.

In Table 2 is displayed the median of the estimated parameters of the patients in the non-severe group and the two 185 severe groups. The parameters that varied the most in their medians were , , and , with orders of magnitude 186 among patient groups. It can be noticed that and values are lower in non-severe patients than severe D patients, 187 however these patients have a viral load clearance similar to severe D patients; this suggests that severe D patients 188 do not produce "quality" antibodies that help to viral shedding, which consequently leads to more severe symptoms. 189 We can also note that although severe D patients have generally better parameters than severe E patients they have a is the author/funder, who has granted medRxiv a license (which was not certified by peer review) holder for this preprint 

In this work, we used the mapper algorithm for the exploration of antibody level data of patients with Using this tool, we identified three groups of patients: non-severe, severe and a group with intermediate severity. We to antibody proliferation and viral clearance by IgG antibody.

In Table 2 we can observe that the severe D patients have a early B cell proliferation, this confers an early response 206 by B cells, which in turn trigger the production of antibodies. This early B cell production in severe patients leads 207 to a rapid proliferation of antibodies, as we can see from the higher values of and in the severe D group. Due 208 to this short response time, the antibodies produced by these severe patients could not have enough time to carry out and IgM levels in the group of patients classified as severe were higher than the non-severe group, however a significant recommended to refer to that work to obtain a broader overview of this analysis tool.

In Table 3 is displayed the parameters used for the analysis of the two data sets, considering a sample per patient 261 for 262 patients, and longitudinal samples of 41 patients. It should be pointed out that we tested different choices of 262 parameters, but we only present the ones with which we obtained the best results for this data set. is the author/funder, who has granted medRxiv a license (which was not certified by peer review) holder for this preprint in logarithmic scale, therefore we use the Root Mean Square Log Error (RMSLE) as cost function and is given by:

where is the number of data points (samples), is the experimental measure of the -th sample and̄ is the predictive 265 output of the model.

As several models can provide the same fit with observed experimental data, it becomes necessary to choose 

where is the number of data points, is the unknown parameters and RSS is the residual sum of squares obtained 271 from the fitting routine. The lowest AIC value of a given model, the best description of the data better respect the other perspective on potential antibody-dependent enhancement of SARS- is the author/funder, who has granted medRxiv a license (which was not certified by peer review) holder for this preprint The copyright this version posted February 24, 2022. ; https://doi.org/10.1101/2022.02.23.22271403 doi: medRxiv preprint

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Viral dynamics in mild and se-327 vere cases of COVID-19. The Lancet Infectious Diseases 0

Antibody responses to 330 sars-cov-2 in patients with covid-19

Cross-reactive antibody response 333 between SARS-CoV-2 and SARS-CoV infections

The half-lives of igg subclasses and specific anti-336 bodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin

Quantifying 339 the Early Immune Response and Adaptive Immune Response Kinetics in Mice Infected with Influenza A Virus

Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm

Ebola virus infection modeling and identifi-346 ability problems